Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of MEDI CAPS. For more details, see the MEDI CAPS quarterly results and MEDI CAPS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.1 |
No. of shares | m | 12.47 |
1 Week | % | -4.8 |
1 Month | % | 16.5 |
1 Year | % | 37.1 |
52 week H/L | Rs | 63.5/34.8 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
MEDI CAPS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 25 | 20 | 47 | 91 | 59 | |
Low | Rs | 11 | 7 | 8 | 37 | 31 | |
Sales per share (Unadj.) | Rs | 38.6 | 32.9 | 47.1 | 56.0 | 39.6 | |
Earnings per share (Unadj.) | Rs | 4.3 | -4.7 | 9.0 | 8.1 | 1.5 | |
Diluted earnings per share | Rs | 4.3 | -4.7 | 9.0 | 8.1 | 1.5 | |
Cash flow per share (Unadj.) | Rs | 5.8 | -3.2 | 10.2 | 9.5 | 2.9 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 76.7 | 72.9 | 84.0 | 93.2 | 95.1 | |
Adj. book value per share | Rs | 76.7 | 72.9 | 84.0 | 93.2 | 95.1 | |
Shares outstanding (eoy) | m | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | |
Price / Sales ratio | x | 0.5 | 0.4 | 0.6 | 1.1 | 1.1 | |
Avg P/E ratio | x | 4.1 | -2.9 | 3.1 | 7.9 | 29.9 | |
P/CF ratio (eoy) | x | 3.0 | -4.3 | 2.7 | 6.7 | 15.5 | |
Price / Book Value ratio | x | 0.2 | 0.2 | 0.3 | 0.7 | 0.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 218 | 172 | 347 | 797 | 559 | |
Total wages/salary | Rs m | 90 | 107 | 50 | 56 | 56 |
MEDI CAPS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 481 | 410 | 587 | 699 | 494 | |
Other income | Rs m | 27 | 29 | 6 | 19 | 16 | |
Total revenues | Rs m | 509 | 439 | 593 | 718 | 510 | |
Gross profit | Rs m | 47 | -68 | 123 | 101 | 52 | |
Depreciation | Rs m | 18 | 18 | 15 | 18 | 17 | |
Interest | Rs m | 1 | 1 | 1 | 1 | 1 | |
Profit before tax | Rs m | 55 | -58 | 112 | 101 | 49 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1 | 0 | 0 | 0 | 31 | |
Profit after tax | Rs m | 54 | -59 | 112 | 100 | 19 | |
Gross profit margin | % | 9.8 | -16.5 | 20.9 | 14.4 | 10.5 | |
Effective tax rate | % | 2.1 | -0.1 | 0 | 0.1 | 62.1 | |
Net profit margin | % | 11.2 | -14.3 | 19.2 | 14.4 | 3.8 |
MEDI CAPS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 420 | 331 | 527 | 667 | 602 | |
Current liabilities | Rs m | 91 | 34 | 93 | 132 | 52 | |
Net working cap to sales | % | 68.3 | 72.5 | 73.9 | 76.6 | 111.5 | |
Current ratio | x | 4.6 | 9.8 | 5.7 | 5.1 | 11.7 | |
Inventory Days | Days | 138 | 199 | 178 | 162 | 240 | |
Debtors Days | Days | 97,496,845 | 39,176,810 | 397 | 526 | 626 | |
Net fixed assets | Rs m | 646 | 621 | 622 | 637 | 658 | |
Share capital | Rs m | 125 | 125 | 125 | 125 | 125 | |
"Free" reserves | Rs m | 831 | 785 | 922 | 1,038 | 1,061 | |
Net worth | Rs m | 956 | 910 | 1,047 | 1,163 | 1,186 | |
Long term debt | Rs m | 1 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 1,066 | 952 | 1,148 | 1,304 | 1,260 | |
Interest coverage | x | 43.0 | -48.9 | 110.1 | 94.1 | 39.4 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | |
Return on assets | % | 5.2 | -6.0 | 9.9 | 7.8 | 1.6 | |
Return on equity | % | 5.6 | -6.4 | 10.7 | 8.6 | 1.6 | |
Return on capital | % | 5.9 | -6.3 | 10.8 | 8.7 | 4.3 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 5.2 | 2.4 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 25 | 10 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 28 | 10 | 0 | 0 | 0 | |
Net fx | Rs m | -28 | -10 | 0 | 0 | 0 |
MEDI CAPS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 60 | 46 | 153 | 70 | -61 | |
From Investments | Rs m | -58 | -58 | -97 | -41 | -26 | |
From Financial Activity | Rs m | -1 | -1 | -1 | 0 | 0 | |
Net Cashflow | Rs m | 2 | -12 | 56 | 29 | -86 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Ramesh Chandra Mittal | COMP SEC: Abhishek Jain | YEAR OF INC: 1983 | BSE CODE: 523144 | FV (Rs): 10 | DIV YIELD (%): - |
More Chemicals & Pesticides Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare MEDI CAPS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.